In line with the Ministry of Health’s (MOH) announcement on 26 November 2025, a significant industry shift is approaching. By 1 April 2026, all insurers must launch new Integrated Shield plan (IP) riders that no longer cover the minimum IP deductibles. Individuals who purchased the old IP riders between 27 November 2025 to 31 March 2026 will eventually have to transit to the new IP riders by their first renewal after 1 April 2028.
A summary of the key changes:
- Co-payment for new IP riders will be capped at $6,000 (up from $3,000).
- Lower premiums for new IP riders.
- IP riders can no longer cover the annual deductible for any ward class
|
Income |
Raffles |
Singlife |
|
|
Main shield plan |
Premium revised up |
Premium revised up |
Premium revised up |
|
Existing IP riders |
No change to premiums |
Premiums revised up for Raffles Key Rider. No change to Raffles Shield Premier Rider or the Raffles Cancer Guard Rider. |
Premium revised up |
|
New IP riders |
Lower premiums |
Lower premiums |
Lower premiums |
These upcoming plans will feature a higher annual co-payment cap of $6,000 (up from the current $3,000), which must be paid on top of the deductible. In exchange for this higher out-of-pocket co-payment, premiums for the new riders are expected to be roughly 30% more affordable than the older IP riders. Here are the key changes to your shield plan and IP riders.
Have a shield plan with a specific insurer? Read our updates on shield plans here:
- Income: New IP Riders 2026: Should I switch to the new Enhanced IncomeShield riders?
- Raffles: A 2026 Update to your Raffles Shield plan and the new Raffles Choice Rider
- Singlife: Singlife Shield & Rider Changes (April 2026): Should You Switch to the New Rider
- HSBC Life: HSBC Life Shield Plan and Rider: The 2026 Guide
1. Income: Enhanced IncomeShield
🛡️ Integrated Shield Plan (IP): Enhanced IncomeShield , IncomeShield
The Enhanced IncomeShield plans will be repriced in April 2026 and this will affect individuals who purchase or renew their shield plans on or after 1 April 2026. The new premiums will see an average premium increase of 13 to 14% for Enhanced Preferred and Advantage plans, and an average of 7% premium increase for the Enhanced Basic plan.
|
Plan Name |
Enhanced IncomeShield Preferred |
Enhanced IncomeShield Advantage |
Enhanced IncomeShield Basic |
|
Ward Entitlement |
Private Hospital |
Class A Ward in public hospitals |
Class B1 Ward in public hospitals |
|
Average Premium Adjustment |
+14% |
+13% |
+7% |
Alongside the repricing, additional benefits are being introduced. These include enhancements to the Pregnancy and Delivery-Related Complications benefit, where the requirement to use a preferred partner has been removed for an extended list of covered conditions. The Cell, Tissue and Gene Therapy (CTGTP) benefit has also been updated, with revised policy wording to include coverage for ancillary treatments.
🛡️IP Riders (Existing): Deluxe Care, and Classic Care riders (To be withdrawn on 1 April 2026)
While premiums and benefits for the existing Deluxe Care and Classic Care riders remain unchanged, Income will introduce the new Optima Care and Essential Care riders on 1 April 2026.
🛡️IP Riders (New): Optima Care and Essential Care riders (To launch on 1 April 2026)
Although the new riders come with a higher annual co-payment cap of $6,000, they offer significant premium savings averaging at 47 to 48% lower when attached to Enhanced IncomeShield Advantage plan, and 23 to 24% lower on average when attached to the Enhanced IncomeShield Preferred plan. Aligning with MOH’s requirements, the new riders will no longer waive deductibles required. They also introduce additional benefits such as coverage for non-MOH-listed gene therapy (CTGTP), extended pre- and post-hospitalisation days, and child-specific coverage like autism testing and critical care payouts. The extended panel and non-panel payment requirement has also been removed for the new Income IP riders.
- Optima Care Rider: Maintains a 5% co-payment for panel doctors but increases the rate to 8% for extended/non-panel providers (up from 5%).
- Essential Care Rider: Rewards panel usage by lowering the co-payment to 7% (down from 10%). Non-panel treatment remains at 10%.
The Optima Care Rider maintains a 5% co-payment for panel providers but introduces a higher 8% co-payment for extended panel and non-panel providers (up from 5% under the Deluxe Care Rider). Meanwhile, the Essential Care Rider rewards users of panel doctors by lowering the co-payment for panel doctors to 7% (down from the 10% required under the Classic Care Rider). Treatment at extended panel or non-panel providers remains at a 10% co-payment for the Essential Care Rider. Ultimately, these new riders serve as a cost-effective alternative for those looking to balance high-quality protection with much more manageable premium costs.
Key differences between the new and old Income IP riders:
|
|
Optima Care rider (To replace Deluxe Care rider) |
Essential Care rider (To replace Classic Care rider) |
|
Co-payment required (Panel) |
Remains at 5% co-payment. Capped amount increases from $3,000 to $6,000. |
Co-payment decreases from 10% to 7% required for treatment on panel providers. Capped amount increases from $3,000 to $6,000. |
|
Co-payment required (Non-Panel) |
Co-payment increases from 5% to 10% required for treatment on extended panel or non-panel providers. Capped amount increases from $3,000 to $6,000.
|
Remains at 10% co-payment for extended panel or non-panel providers. Capped amount increases from $3,000 to $6,000. |
|
Extended panel and non-panel paymeent |
Not required. |
Not required. |
|
Annual Deductible |
Required (Previously waived under the Deluxe Care Rider) |
Required (Previously waived under the Classic Care Rider) |
|
Cancer drug limits |
No change when compared to Deluxe Care rider. |
No change when compared to Classic Care rider. |
|
New benefits |
|
|
2. Raffles Health Insurance: Raffles Shield
🛡️Integrated Shield Plan (IP): Raffles Shield
Premiums for Raffles Shield plans will be revised for the first time since 2018. The Raffles Shield Private plan will see the largest adjustment, with premiums increasing by an average of 61%. Meanwhile, Raffles Shield A will see an average increase of 25%, the lowest among the plans, while Raffles Shield B premiums will rise by an average of 31%.
|
Plan Name |
Raffles Shield Private |
Raffles Shield A |
Raffles Shield B |
|
Ward Entitlement |
Private Hospital |
Class A Ward in public hospitals |
Class B1 Ward in public hospitals |
|
Average Premium Adjustment |
+61% |
+25% |
+31% |
Raffles Shield Private, A, and B plans will also be enhanced for Pregnancy Complications benefit to cover the list of serious pregnancy and delivery complications as stated in the Ministry of Health (MOH) website. Additional outpatient benefits will also be introduced to align with MediShield Life’s enhanced outpatient benefits.
🛡️ IP Riders (Existing): Raffles Key Rider (To be withdrawn on 1 April 2026), Raffles Premier Rider, and Raffles Cancer Guard Rider
Raffles Key Rider premiums are also set to increase across all plans, with the most significant adjustment being a 155% average increase when attached to Raffles Shield Private. This is followed by an average increase of 71% when attached to Raffles Shield A with the Raffles Hospital option, 66% when attached to Raffles Shield A, and 58% when attached to Raffles Shield B. On 1 April 2026, Raffles will also introduce the new Raffles Choice Rider to replace Raffles Key Rider.
There will be no changes to the premiums for the Raffles Shield Premier Rider or the Raffles Cancer Guard Rider.
🛡️ IP Rider (New): Raffles Choice Rider (To launch on 1 April 2026)
A new Raffles Choice rider will be launched on 1 April 2026 to replace the old Raffles Key Rider. The new Raffles Choice Rider maintains co-payment at 5% but will see a higher annual co-payment cap of $6,000. The new rider will also no longer waive the annual deductibles required. Premiums for the new Raffles Choice Rider will be 50% cheaper than the Raffles Key Rider premiums.
|
|
Raffles Choice Rider (To replace Raffles Key rider) |
|
Co-payment required (Panel) |
Remains at 5% co-payment. Capped amount increases from $3,000 to $6,000. |
|
Co-payment required (Non-Panel) |
Remains unchanged at 5%. No cap on co-payment required for non-panel treatment. |
|
Cancer drug limits not on the CDL (Non-CDL) |
No change. Up to $5,000 annual limit. |
|
Annual Deductible |
Required (Previously waived under the Raffles Key Rider) |
3. Singlife Shield
🛡️ Integrated Shield Plan (IP): Singlife Shield
There will be a premium adjustment for Singlife Shield plan, with premiums for Singlife Shield Plan 1 increasing by 10% on average, and Plan 2 and 3 (Class A or B1 ward plans) increasing by an average of 0 to1%.
|
Plan Name |
Singlife Shield Plan 1 |
Singlife Shield Plan 2 |
Singlife Shield Plan 3 |
|
Ward Entitlement |
Private Hospital |
Class A Ward in public hospitals |
Class B1 Ward in public hospitals |
|
Average Premium Adjustment |
+10% |
+1% |
+0% |
Other key enhancements include increasing the policy year limit for Plan 2 to a market-leading $1.2 million and revising the Cell, Tissue, and Gene Therapy Benefit (CTGTP) coverage to align specifically with medications listed on the Ministry of Health’s (MOH) approved CTGTP list.
🛡️IP Riders (Existing): Private Prime, Private Lite, Public Prime, Public Lite (To be withdrawn on 1 April 2026).
Premiums for Singlife IP riders will see adjustments across several tiers. Singlife Shield Plan 1 (Private Hospital) will experience an average increase of 78% for Private Prime rider and 18% for Private Lite rider. For Singlife Shield Plan 2, premiums will rise by an average of 14% for Public Prime rider and 19% for Public Lite rider. There will be no changes to the IP riders attachable to Plan 3.
A new recovery support benefit will also be introduced, offering 2 years per lifetime coverage of up to $20,000 for home nursing and rehabilitation services and will be made available to those who qualify for the Severe Disability Benefit. Note that this benefit is only available for individuals who have both a Singlife Health Plus rider and a Singlife CareShield or ElderShield plan.
🛡️IP Riders (New): Singlife Health Plus Private or Public rider (To launch on 1 April 2026)
The new rider simplifies the structure to a single rider type, replacing the previous Prime and Lite options. It introduces a mandatory deductible for all providers, meaning IP deductibles are no longer covered, and the co-insurance cap increases from $3,000 to $6,000.
Other changes include capping Outpatient Cancer Drug Treatment on the CDL at $10,000 per month for Singlife Health Plus Private (revised from the previous 15 times MediShield Life benefit) and reducing the non-CDL benefit to $10,000 per month for Singlife Health Plus Private (from $15,000 previously). The ward downgrade benefit will be removed from the new rider.
The new Singlife Health Plus Private and Public riders offer significant premium savings compared to the previous Private Prime and Public Prime riders. However, policyholders on the existing Lite riders may see more modest savings at around 10% on average when attached to Singlife Shield Plan 1 and 2, and about 7% for Plan 3.
|
Singlife Health Plus Private/Public (To replace Singlife Health Plus Private Prime, Private Lite, Public Prime, Public Lite) |
|
|
Co-payment required |
Remains at 5% co-payment. Capped amount increases from $3,000 to $6,000. |
|
Annual Deductible |
Singlife Shield annual deductible will now apply to all riders (previously no deductible required for preferred providers). |
|
Outpatient Cancer Drug Treatment benefit |
For treatment on the Cancer Drug List (CDL): Private rider will now cap this benefit to $10,000 per month, subject to co-insurance. No change for Public rider. For non-CDL treatment: Benefit will be revised down to $10,000 per month subject to co-insurance for Private rider (down from the previous $15,000 per month). No change for Public rider. |
|
Other benefits |
Removal of Ward Downgrade benefit. |
Check Your Coverage, Not Your Savings. Review Your Shield Plan and Get Rewarded!
With medical inflation on the rise, don’t let your hospitalisation plan become an afterthought. Review your Integrated Shield Plan (IP) and IP rider with our FSM insurance specialist to ensure your coverage is up to date and get rewarded for doing so. Receive a Cash Account Reward of up to $50 and enjoy up to 45% commission rebates on eligible plans, or get a $5 bonus when transferring in an eligible policy from Income or Raffles.
|
Action |
Cash Reward |
|
1. Purchase a new Integrated Shield plan (IP) or IP Rider |
$50 and up to 45% commission rebate |
|
2. Transfer-in for an eligible Shield plan (only applicable to Shield plans from Income and Raffles) |
$5 for eligible policies |
Don’t wait for a medical emergency to reveal gaps in your coverage. Click the button below to speak to us for a complimentary review to optimise your protection today.
Have a question? Speak to us and get up to 45% commission rebate on eligible policies
Click here to schedule your review and claim your reward 🤩
You may also be interested in:
-
New IP Riders 2026: Should I switch to the new Enhanced IncomeShield riders?
Singlife Shield & Rider Changes (April 2026): Should You Switch to the New Rider?
A 2026 Update to your Raffles Shield plan and the new Raffles Choice Rider
Your 2026 Guide to Critical Illness Coverage: Pay Less, Get More
Why is Term Life Insurance Cheaper in Singapore? (A Regional Comparison)
|
Available Products on FSMOne Insurance |
|
Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial) from AIA, AIG, Allianz, China Taiping, Cigna, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Henner, Income, Manulife, MSIG, Raffles Health Insurance, Singlife, Sompo, Tokio Marine, and QBE. *Please check with our team if the product you want is available on FSMOne Insurance |
*Terms and Conditions:
- This Check Your Coverage campaign (the “Campaign”) is valid from 27 March 2026 to 30 June 2026, inclusive of both dates (the “Campaign Period”).
- You will receive the $5 or $50 Cash Reward (the “Reward”) into the FSMOne Cash Account when you successfully transfer-in or purchase and incept an integrated shield plan via FSMOne during the Campaign period. The Reward will be processed within 8 weeks after the end of the Campaign Period.
- For avoidance of doubt, FSMOne will use the insurer’s effected request date as the date of successful transfer. Policies not transferred in or incepted within the Campaign Period dates will not be eligible for the Reward.
- Policies eligible for transfer-in Reward are: Enhanced IncomeShield Basic, Enhanced IncomeShield Advantage, and Enhanced IncomeShield Preferred, IncomeShield Plan C, IncomeShield Plan B, IncomeShield Plan A, IncomeShield Plan P, Raffles Shield Private, Raffles Shield A, Raffles Shield B, Raffles Shield Standard.
- There is no limit to the number of Reward(s) each client is entitled to. You may purchase or transfer-in multiple policies during the Campaign Period to receive multiple Rewards.
- Shield plan transfers made internally within iFAST Financial are not eligible for the Reward (i.e. Transfer(s) made from iFAST Financial, or iFAST Global Markets). Plans previously serviced by iFAST Financial that were transferred out and later transferred-in again will also not qualify for the reward.
- Client must be a FSMOne account holder to receive the Reward. New account holders are also eligible for this promotion. Clients without a FSMOne account will not be eligible for any Reward. Name of the policyholder must match the name registered with the FSMOne Account Number to be eligible for the Reward.
- FSMOne reserves the right to replace the reward of similar value without prior notification.
- FSMOne reserves the right to amend the Terms and Conditions without prior notification and has the final decision on all matters relating to this Campaign. Any appeals will not be entertained.
Information obtained from:
https://www.raffleshealthinsurance.com/wp-content/uploads/2025/09/Raffles-Shield-and-Riders-Product-Summary.pdf
https://www.raffleshealthinsurance.com/resource-centre/downloads/
https://www.income.com.sg/health-insurance/enhanced-incomeshield
https://singlife.com/en/medical-insurance/shield
Information retrieved 16 March 2026.
Disclaimer:
More information on commission rebates can be found here.
All materials and content found in this advertisement are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product. This advertisement is not a contract of insurance.
Insurance products are underwritten by the respective insurance partners and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to review the specific terms, conditions and exclusions in the relevant policy contract.
You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.
While iFAST and its third-party providers strive to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice.
The comparisons and opinions provided are based on publicly available data/information and are intended to provide a general overview of the insurance products discussed. These comparisons do not cover all available products and may not fully illustrate every aspect of the products discussed.
Purchasing a life insurance policy is a long-term commitment, and early termination may involve significant costs. The surrender value, if any, may be zero or less than the total premiums paid.
This advertisement has not been reviewed by the Monetary Authority of Singapore.
All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.
Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).
iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.